PriceTargets.com logo

Integral Ad Science - IAS Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $11.52
  • Forecasted Upside: 12.30%
  • Number of Analysts: 14
  • Breakdown:
  • 0 Sell Ratings
  • 14 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$10.26 As of 12/4/2025 05:00 PM ET
▼ -0.01 (-0.10%)

This chart shows the closing price for IAS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Integral Ad Science Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for IAS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for IAS

Analyst Price Target is $11.52
▲ +12.30% Upside Potential
This price target is based on 14 analysts offering 12 month price targets for Integral Ad Science in the last 3 months. The average price target is $11.52, with a high forecast of $17.00 and a low forecast of $10.00. The average price target represents a 12.30% upside from the last price of $10.26.

This chart shows the closing price for IAS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 14 investment analysts is to hold stock in Integral Ad Science. This rating has held steady since September 2025, when it changed from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 11 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
6/12/2024
  • 0 strong buy ratings
  • 9 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2024
  • 0 strong buy ratings
  • 8 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
3/9/2025
  • 0 strong buy ratings
  • 6 buy ratings
  • 6 hold ratings
  • 0 sell ratings
Ratings as of
6/7/2025
  • 0 strong buy ratings
  • 6 buy ratings
  • 6 hold ratings
  • 0 sell ratings
Ratings as of
9/5/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 14 hold ratings
  • 0 sell ratings
Ratings as of
11/4/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 14 hold ratings
  • 0 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 14 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/14/2025Weiss RatingsReiterated RatingHold (C) ➝ Hold (C)
9/27/2025Weiss RatingsReiterated RatingHold (C-) ➝ Hold (C-)
9/25/2025Stifel NicolausReiterated RatingBuy ➝ Hold$14.00 ➝ $10.30
9/25/2025Robert W. BairdBoost TargetNeutral ➝ Neutral$9.00 ➝ $10.30
9/25/2025Raymond James FinancialDowngradeOutperform ➝ Market Perform
9/24/2025Loop CapitalDowngradeBuy ➝ Hold$10.30
9/24/2025OppenheimerDowngradeOutperform ➝ Market Perform
9/24/2025BMO Capital MarketsSet TargetOutperform ➝ Market Perform$10.30
9/24/2025Craig HallumDowngradeStrong-Buy ➝ Hold
9/24/2025Truist FinancialDowngradeStrong-Buy ➝ Hold
9/24/2025BMO Capital MarketsDowngradeOutperform ➝ Hold
8/8/2025Raymond James FinancialLower TargetOutperform ➝ Outperform$13.00 ➝ $11.00
8/8/2025BarclaysBoost TargetEqual Weight ➝ Equal Weight$9.00 ➝ $10.00
7/22/2025Stifel NicolausBoost TargetBuy ➝ Buy$13.00 ➝ $14.00
5/13/2025Raymond James FinancialBoost TargetOutperform ➝ Outperform$11.00 ➝ $13.00
5/13/2025BarclaysBoost TargetEqual Weight ➝ Equal Weight$7.00 ➝ $9.00
5/5/2025Raymond James FinancialLower TargetOutperform ➝ Outperform$16.00 ➝ $11.00
4/23/2025Stifel NicolausLower TargetBuy ➝ Buy$15.00 ➝ $13.00
4/21/2025BarclaysLower TargetEqual Weight ➝ Equal Weight$14.00 ➝ $7.00
4/17/2025Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$13.50 ➝ $12.50
3/28/2025Baird R WDowngradeStrong-Buy ➝ Hold
3/28/2025Robert W. BairdReiterated RatingOutperform ➝ Neutral$16.00 ➝ $9.00
3/3/2025Morgan StanleyReiterated RatingMixed ➝ Mixed
3/3/2025Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$13.00 ➝ $13.50
3/3/2025Truist FinancialBoost TargetBuy ➝ Buy$16.00 ➝ $17.00
2/28/2025BenchmarkReiterated RatingHold ➝ Hold
2/28/2025BarclaysReiterated RatingEqual Weight ➝ Equal Weight
2/28/2025ScotiabankInitiated CoverageSector Perform ➝ Sector Perform$10.00 ➝ $12.00
2/28/2025OppenheimerReiterated RatingOutperform ➝ Outperform
12/5/2024ScotiabankInitiated CoverageSector Perform$10.00
11/14/2024BenchmarkReiterated RatingHold
11/13/2024Piper SandlerLower TargetOverweight ➝ Overweight$18.00 ➝ $16.00
11/13/2024Truist FinancialLower TargetBuy ➝ Buy$18.00 ➝ $16.00
11/13/2024Craig HallumLower TargetBuy ➝ Buy$18.00 ➝ $16.00
11/13/2024OppenheimerLower TargetOutperform ➝ Outperform$20.00 ➝ $18.00
8/5/2024BarclaysBoost TargetEqual Weight ➝ Equal Weight$12.00 ➝ $13.00
8/5/2024BenchmarkReiterated RatingHold
8/2/2024Raymond James FinancialBoost TargetOutperform ➝ Outperform$13.00 ➝ $15.00
7/23/2024Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$12.00 ➝ $13.00
5/10/2024Craig HallumLower TargetBuy ➝ Buy$20.00 ➝ $18.00
5/10/2024Raymond James FinancialLower TargetOutperform ➝ Outperform$16.00 ➝ $13.00
5/7/2024BenchmarkReiterated RatingHold
4/30/2024Loop CapitalInitiated CoverageBuy$15.00
4/16/2024Morgan StanleyReiterated RatingOverweight ➝ Equal Weight$18.00 ➝ $12.00
4/15/2024BarclaysLower TargetEqual Weight ➝ Equal Weight$16.00 ➝ $12.00
2/28/2024BarclaysLower TargetEqual Weight ➝ Equal Weight$17.00 ➝ $16.00
2/28/2024Piper SandlerLower TargetOverweight ➝ Overweight$20.00 ➝ $18.00
2/28/2024BMO Capital MarketsLower TargetOutperform ➝ Outperform$18.00 ➝ $16.00
2/28/2024Truist FinancialLower TargetBuy ➝ Buy$26.00 ➝ $17.00
2/28/2024OppenheimerLower TargetOutperform ➝ Outperform$25.00 ➝ $20.00
2/28/2024Raymond James FinancialDowngradeStrong-Buy ➝ Outperform$20.00 ➝ $16.00
1/11/2024Bank of AmericaInitiated CoverageBuy$19.00
1/9/2024BMO Capital MarketsInitiated CoverageOutperform$18.00
11/3/2023Piper SandlerLower TargetOverweight ➝ Overweight$23.00 ➝ $20.00
11/3/2023Morgan StanleyLower TargetOverweight ➝ Overweight$21.50 ➝ $16.50
10/12/2023BarclaysLower TargetEqual Weight ➝ Equal Weight$21.00 ➝ $15.00
9/27/2023MacquarieInitiated CoverageOutperform$16.00
8/18/2023Robert W. BairdInitiated CoverageOutperform$19.00
8/4/2023Morgan StanleyReiterated RatingOverweight ➝ Overweight$21.50
8/4/2023Raymond James FinancialLower TargetStrong-Buy ➝ Strong-Buy$23.00 ➝ $22.00
7/21/2023Stifel NicolausBoost TargetBuy$20.00 ➝ $23.00
7/20/2023Truist FinancialInitiated CoverageBuy$25.00
7/19/2023BarclaysBoost Target$20.00 ➝ $21.00
7/14/2023Piper SandlerBoost Target$21.00 ➝ $23.00
7/10/2023Piper SandlerInitiated CoverageOverweight
6/14/2023Craig HallumBoost Target$20.00 ➝ $23.00
6/14/2023Raymond James FinancialBoost Target$19.00 ➝ $23.00
6/14/2023BarclaysBoost Target$17.00 ➝ $20.00
6/6/2023BenchmarkInitiated CoverageHold
5/5/2023Craig HallumBoost Target$18.00 ➝ $20.00
5/5/2023BarclaysBoost Target$16.00 ➝ $17.00
4/24/2023Stifel NicolausBoost Target$15.00 ➝ $19.00
4/17/2023BarclaysBoost TargetEqual Weight$11.00 ➝ $16.00
4/12/2023KeyCorpInitiated CoverageSector Weight ➝ Sector Weight
3/31/2023Craig HallumInitiated CoverageBuy$18.00
3/3/2023Raymond James FinancialBoost TargetStrong-Buy$12.00 ➝ $17.00
3/3/2023BarclaysBoost Target$10.00 ➝ $11.00
1/19/2023Wells Fargo & CompanyLower TargetOverweight$16.00 ➝ $15.00
1/18/2023Morgan StanleyBoost TargetOverweight$12.00 ➝ $13.00
11/18/2022BarclaysBoost TargetEqual Weight$8.00 ➝ $10.00
11/16/2022Evercore ISILower Target$13.00
11/11/2022Raymond James FinancialLower TargetStrong-Buy$15.00 ➝ $12.00
10/18/2022BarclaysLower TargetEqual Weight$10.00 ➝ $8.00
8/15/2022BarclaysLower Target$10.00
8/9/2022BarclaysLower Target$10.00
8/8/2022Morgan StanleyLower TargetOverweight$13.00 ➝ $12.00
8/8/2022Wells Fargo & CompanyLower TargetOverweight$28.00 ➝ $21.00
8/8/2022OppenheimerLower TargetOutperform$16.00 ➝ $15.00
8/4/2022Jefferies Financial GroupLower Target$18.00 ➝ $15.00
6/24/2022Morgan StanleyLower TargetOverweight$15.00 ➝ $13.00
5/12/2022OppenheimerLower Target$24.00 ➝ $19.00
5/12/2022BarclaysLower Target$17.00 ➝ $12.00
4/19/2022BarclaysLower TargetEqual Weight$20.00 ➝ $17.00
3/21/2022Raymond James FinancialUpgradeOutperform ➝ Strong-Buy$26.00 ➝ $27.00
3/4/2022OppenheimerLower TargetOutperform$30.00 ➝ $24.00
3/4/2022Raymond James FinancialLower TargetOutperform$28.00 ➝ $26.00
3/4/2022Stifel NicolausBoost TargetBuy$25.00 ➝ $26.00
2/1/2022Stifel NicolausInitiated CoverageBuy$25.00
1/19/2022Morgan StanleyBoost Target$25.00 ➝ $27.00
1/12/2022BarclaysLower Target$26.00 ➝ $23.00
11/19/2021Evercore ISIReiterated RatingBuy$30.00
11/11/2021Raymond James FinancialBoost TargetOutperform$22.00 ➝ $28.00
9/17/2021Jefferies Financial GroupBoost TargetBuy$23.00 ➝ $28.00
8/13/2021BarclaysBoost TargetEqual Weight$21.00 ➝ $22.00
8/13/2021BMO Capital MarketsBoost TargetOutperform$25.00 ➝ $27.00
8/13/2021Morgan StanleyBoost TargetOverweight$23.00 ➝ $24.00
7/26/2021Jefferies Financial GroupInitiated CoverageBuy$23.00
7/26/2021Raymond James FinancialInitiated CoverageOutperform$22.00
7/26/2021OppenheimerReiterated RatingOutperform$23.00
7/26/2021Morgan StanleyInitiated CoverageOverweight$23.00
7/26/2021Wells Fargo & CompanyInitiated CoverageOverweight$26.00
7/26/2021BarclaysInitiated CoverageEqual Weight$21.00
7/26/2021BMO Capital MarketsInitiated CoverageOutperform$25.00
7/25/2021Evercore ISIInitiated CoverageOutperform$23.00
(Data available from 12/4/2020 forward)

News Sentiment Rating

0.92 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 15 very positive mentions
  • 8 positive mentions
  • 8 negative mentions
  • 1 very negative mentions
Mentions as of
5/8/2025
  • 19 very positive mentions
  • 18 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/7/2025
  • 4 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
7/7/2025
  • 18 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/6/2025
  • 16 very positive mentions
  • 12 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
9/5/2025
  • 19 very positive mentions
  • 23 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
10/5/2025
  • 10 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2025
  • 7 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/4/2025

Current Sentiment

  • 7 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Integral Ad Science logo
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video. Its digital media quality solutions offer ad fraud detection and prevention, viewability, brand safety and suitability, contextual targeting, inventory yield management, and reporting. In addition, the company offers Quality Impressions, a metric designed to verify that digital ads are served to a real person rather than a bot, viewable on-screen, and presented in a brand-safe and suitable environment in the correct geography; Context Control solution that delivers contextual targeting and brand suitability capabilities; pre-bid programmatic and post-bid verification solutions for advertisers; and optimization and verification solutions for publishers. It serves advertisers and agencies, publishers, and supply side platforms. The company was founded in 2009 and is headquartered in New York, New York.
Read More

Today's Range

Now: $10.26
Low: $10.26
High: $10.28

50 Day Range

MA: $10.23
Low: $10.16
High: $10.28

52 Week Range

Now: $10.26
Low: $6.26
High: $11.43

Volume

2,401,570 shs

Average Volume

1,223,768 shs

Market Capitalization

$1.72 billion

P/E Ratio

36.64

Dividend Yield

N/A

Beta

1.59

Frequently Asked Questions

What sell-side analysts currently cover shares of Integral Ad Science?

The following equities research analysts have issued reports on Integral Ad Science in the last year: Baird R W, Barclays PLC, Benchmark Co., BMO Capital Markets, Craig Hallum, Loop Capital, Morgan Stanley, Oppenheimer Holdings, Inc., Raymond James Financial, Inc., Robert W. Baird, Scotiabank, Stifel Nicolaus, Truist Financial Corporation, Wall Street Zen, and Weiss Ratings.
View the latest analyst ratings for IAS.

What is the current price target for Integral Ad Science?

0 Wall Street analysts have set twelve-month price targets for Integral Ad Science in the last year. Their average twelve-month price target is $11.52, suggesting a possible upside of 12.1%. Truist Financial Corporation has the highest price target set, predicting IAS will reach $17.00 in the next twelve months. Barclays PLC has the lowest price target set, forecasting a price of $10.00 for Integral Ad Science in the next year.
View the latest price targets for IAS.

What is the current consensus analyst rating for Integral Ad Science?

Integral Ad Science currently has 14 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in IAS, but not buy more shares or sell existing shares.
View the latest ratings for IAS.

What other companies compete with Integral Ad Science?

Other companies that are similar to Integral Ad Science include Global-e Online, GitLab, NiCE, GDS and Sportradar Group. Learn More about companies similar to Integral Ad Science.

How do I contact Integral Ad Science's investor relations team?

The company's listed phone number is 646-278-4871 and its investor relations email address is [email protected]. The official website for Integral Ad Science is integralads.com. Learn More about contacing Integral Ad Science investor relations.